Treatment of chronic botulinum toxins type a. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy5

Upper Extremity Sweat Glands Facial Muscles Neuromuscular Junction Oculomotor Muscles

Organisms6

Clostridium botulinum Clostridium botulinum type A Clostridium botulinum type E Clostridium botulinum type B Clostridium Clostridium botulinum type F

Diseases23

Muscle Spasticity Botulism Blepharospasm Torticollis Hyperhidrosis Sialorrhea Hemifacial Spasm Paraparesis, Spastic Hypohidrosis Cerebral Palsy Spasm Hemiplegia Fissure in Ano Meige Syndrome Stroke Dystonia Esophageal Achalasia Dystonic Disorders Sweating, Gustatory Spinal Cord Injuries Urinary Bladder, Overactive Equinus Deformity Toxemia

Chemicals and Drugs20

Botulinum Toxins, Type A Neuromuscular Agents Botulinum Toxins Anti-Dyskinesia Agents Botulinum Antitoxin Muscle Relaxants, Central Neurotoxins Shiga Toxin 2 Tetanus Toxin Parasympatholytics Shiga Toxin 1 Cholera Toxin T-2 Toxin Shiga Toxins Synaptosomal-Associated Protein 25 Enterotoxins Bacterial Toxins Toxins, Biological Antitoxins Toxoids

Analytical, Diagnostic and Therapeutic Techniques and Equipment14

Injections, Intramuscular Cosmetic Techniques Injections Cryoanesthesia Treatment Outcome Pain Measurement Gait Range of Motion, Articular Double-Blind Method Quality-Adjusted Life Years Lethal Dose 50 Follow-Up Studies Prospective Studies Rejuvenation

Phenomena and Processes5

Skin Aging Gait Range of Motion, Articular Lethal Dose 50 Dose-Response Relationship, Drug

Information Science1

Quality-Adjusted Life Years

Health Care7

Treatment Outcome Double-Blind Method Quality-Adjusted Life Years Follow-Up Studies Patient Satisfaction Cost-Benefit Analysis Prospective Studies

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Information Science Health Care

Botulinum Toxins, Type A Neuromuscular Agents Botulinum Toxins Muscle Spasticity Anti-Dyskinesia Agents Clostridium botulinum Injections, Intramuscular Botulism Blepharospasm Botulinum Antitoxin Torticollis Hyperhidrosis Sialorrhea Cosmetic Techniques Hemifacial Spasm Paraparesis, Spastic Skin Aging Muscle Relaxants, Central Hypohidrosis Injections Cerebral Palsy Cryoanesthesia Spasm Hemiplegia Upper Extremity Neurotoxins Shiga Toxin 2 Treatment Outcome Sweat Glands Pain Measurement Tetanus Toxin Fissure in Ano Meige Syndrome Clostridium botulinum type A Parasympatholytics Clostridium botulinum type E Stroke Shiga Toxin 1 Gait Cholera Toxin Range of Motion, Articular Double-Blind Method Dystonia Esophageal Achalasia Facial Muscles Dystonic Disorders T-2 Toxin Quality-Adjusted Life Years Shiga Toxins Sweating, Gustatory Spinal Cord Injuries Lethal Dose 50 Dose-Response Relationship, Drug Synaptosomal-Associated Protein 25 Enterotoxins Neuromuscular Junction Bacterial Toxins Follow-Up Studies Patient Satisfaction Toxins, Biological Antitoxins Oculomotor Muscles Urinary Bladder, Overactive Cost-Benefit Analysis Equinus Deformity Prospective Studies Clostridium botulinum type B Clostridium Rejuvenation Toxoids Clostridium botulinum type F Toxemia

No FAQ available that match "treatment of chronic botulinum toxins type a"